c-Abl antagonizes the YAP oncogenic function
R Keshet1, J Adler1, I Ricardo Lax1
1Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Abstract:
YES-associated protein (YAP) is a central transcription coactivator that functions as an oncogene in a number of experimental systems. However, under DNA damage, YAP activates pro-apoptotic genes in conjunction with p73. This program switching is mediated by c-Abl (Abelson murine leukemia viral oncogene) via phosphorylation of YAP at the Y357 residue (pY357). YAP as an oncogene coactivates the TEAD (transcriptional enhancer activator domain) family transcription factors. Here we asked whether c-Abl regulates the YAP-TEAD functional module. We found that DNA damage, through c-Abl activation, specifically depressed YAP-TEAD-induced transcription. Remarkably, c-Abl counteracts YAP-induced transformation by interfering with the YAP-TEAD transcriptional program. c-Abl induced TEAD1 phosphorylation, but the YAP-TEAD complex remained unaffected. In contrast, TEAD coactivation was compromised by phosphomimetic YAP Y357E mutation but not Y357F, as demonstrated at the level of reporter genes and endogenous TEAD target genes. Furthermore, YAP Y357E also severely compromised the role of YAP in cell transformation, migration, anchorage-independent growth, and epithelial-to-mesenchymal transition (EMT) in human mammary MCF10A cells. These results suggest that YAP pY357 lost TEAD transcription activation function. Our results demonstrate that YAP pY357 inactivates YAP oncogenic function and establish a role for YAP Y357 phosphorylation in cell-fate decision.
Insights
DNA damage triggers c-Abl kinase to phosphorylate YES-associated protein (YAP) at Y357. This phosphorylation inactivates YAP
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- YES-associated protein (YAP) is a key transcription coactivator and oncogene.
- YAP's function shifts under DNA damage, activating pro-apoptotic genes with p73.
- This switch is mediated by c-Abl (Abelson murine leukemia viral oncogene) through YAP phosphorylation at Y357 (pY357).
Purpose of the Study:
- To investigate if c-Abl regulates the YAP-TEAD (transcriptional enhancer activator domain) functional module.
- To determine the role of YAP Y357 phosphorylation in YAP's oncogenic functions.
Main Methods:
- Investigated the effect of DNA damage and c-Abl activation on YAP-TEAD transcription.
- Analyzed TEAD1 phosphorylation and YAP-TEAD complex integrity.
- Utilized phosphomimetic YAP Y357E and Y357F mutations to assess TEAD coactivation.
- Assessed YAP's role in cell transformation, migration, anchorage-independent growth, and EMT in MCF10A cells.
Main Results:
- DNA damage, via c-Abl, significantly reduced YAP-TEAD-induced transcription.
- c-Abl counteracts YAP's oncogenic transformation by disrupting the YAP-TEAD transcriptional program.
- YAP Y357E mutation, unlike Y357F, impaired TEAD coactivation and YAP's oncogenic activities.
- YAP phosphorylation at Y357 (pY357) was shown to abolish YAP's TEAD transcription activation function.
Conclusions:
- YAP phosphorylation at Y357 by c-Abl inactivates its oncogenic function.
- YAP Y357 phosphorylation plays a critical role in cell-fate decisions.
- This mechanism highlights how YAP's function is regulated in response to DNA damage.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
09:55All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
Related Concept Videos
Abnormal Proliferation
Anaphase Promoting Complex
Induced Pluripotent Stem Cells
Somatic...
Inhibition of Cdk Activity
The Intrinsic Apoptotic Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
